Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Up 173.1% in May

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 74,992 shares, a growth of 173.1% from the May 14th total of 27,456 shares. Based on an average daily volume of 283,609 shares, the short-interest ratio is presently 0.3 days. Approximately 0.0% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on SGIOY. The Goldman Sachs Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research report on Wednesday, April 8th. Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Shionogi & Co., Ltd. Unsponsored ADR presently has an average rating of “Hold”.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 0.2%

Shares of SGIOY stock opened at $8.65 on Friday. Shionogi & Co., Ltd. Unsponsored ADR has a 52-week low of $7.65 and a 52-week high of $12.00. The company has a 50-day simple moving average of $9.75 and a two-hundred day simple moving average of $9.88. The company has a market capitalization of $14.72 billion, a price-to-earnings ratio of 10.81, a PEG ratio of 3.32 and a beta of 0.08. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.21 and a current ratio of 5.84.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 14.09%. The firm had revenue of $881.71 million during the quarter, compared to the consensus estimate of $895.52 million. Research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.81 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.